RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cogent Biosciences Stock

Cogent Biosciences Debt 2025

Cogent Biosciences Debt

-98.17 USD

Ticker

COGT

ISIN

US19240Q2012

WKN

A2QJAY

In 2025, Cogent Biosciences's total debt was -98.17 USD, a 84.42% change from the -53.23 USD total debt recorded in the previous year.

Cogent Biosciences Aktienanalyse

What does Cogent Biosciences do?

Cogent Biosciences Inc is a biotechnology company that was founded in 2015. The company is headquartered in Cambridge, Massachusetts and is listed on NASDAQ under the ticker symbol COGT. Cogent Biosciences specializes in the development of drugs for the treatment of cancer and other serious illnesses. Cogent Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Cogent Biosciences's Debt Structure

Cogent Biosciences's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Cogent Biosciences's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Cogent Biosciences’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Cogent Biosciences’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Cogent Biosciences stock

What is the debt of Cogent Biosciences this year?

Cogent Biosciences has a debt level of -98.17 USD this year.

What was the debt of Cogent Biosciences compared to the previous year?

The debt of Cogent Biosciences has increased by 84.42% compared to the previous year increased.

What are the consequences of high debt for investors in Cogent Biosciences?

High debt can pose a risk for investors of Cogent Biosciences, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Cogent Biosciences?

Low debt means that Cogent Biosciences has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Cogent Biosciences affect the company?

An increase in debt of Cogent Biosciences can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Cogent Biosciences affect the company?

A reduction in debt of Cogent Biosciences can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Cogent Biosciences?

Some factors that can influence the debt of Cogent Biosciences include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Cogent Biosciences so important for investors?

The debts of Cogent Biosciences are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Cogent Biosciences take to change the debt?

To change the debt, Cogent Biosciences can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Cogent Biosciences pay?

Over the past 12 months, Cogent Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cogent Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Cogent Biosciences?

The current dividend yield of Cogent Biosciences is .

When does Cogent Biosciences pay dividends?

Cogent Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cogent Biosciences?

Cogent Biosciences paid dividends every year for the past 0 years.

What is the dividend of Cogent Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cogent Biosciences located?

Cogent Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cogent Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cogent Biosciences from 6/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/27/2025.

When did Cogent Biosciences pay the last dividend?

The last dividend was paid out on 6/27/2025.

What was the dividend of Cogent Biosciences in the year 2024?

In the year 2024, Cogent Biosciences distributed 0 USD as dividends.

In which currency does Cogent Biosciences pay out the dividend?

The dividends of Cogent Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cogent Biosciences

Our stock analysis for Cogent Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cogent Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.